A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500821-34-00

Acronym

MK-0482-001

Enrollment

Registered

2023-07-21

Start date

2021-06-15

Completion date

2025-02-17

Last updated

2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026